Magda Bahcall
3PUBLICATIONS
73CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Apr 02, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors.Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti
|Nov 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance.Magda Bahcall, Cloud P Paweletz, Yanan Kuang
|Sep 13, 2021
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer.Pınar Özden Eser, Raymond M Paranal, Jieun Son
Pageof 1
Frequent Collaborators
3 joint publications
Pasi A Jänne
2 joint publications
Kshiti H Dholakia
1 joint publications
Pınar Özden Eser
1 joint publications
Jieun Son
1 joint publications
Yanan Kuang
1 joint publications
Heidi M Haikala
1 joint publications
Ciric To
1 joint publications
Jeffrey J Okoro
1 joint publications
Jihyun Choi
1 joint publications
Atsuko Ogino
